van de Kar NCAJ - Search Results

1

Eculizumab in atypical hemolytic uremic syndrome: strategies toward restrictive use.

Wijnsma KL, Duineveld C, Wetzels JFM, van de Kar NCAJ. Wijnsma KL, et al. Among authors: van de kar ncaj. Pediatr Nephrol. 2019 Nov;34(11):2261-2277. doi: 10.1007/s00467-018-4091-3. Epub 2018 Nov 6. Pediatr Nephrol. 2019. PMID: 30402748 Free PMC article. Review.

2

Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome.

Ariceta G, Besbas N, Johnson S, Karpman D, Landau D, Licht C, Loirat C, Pecoraro C, Taylor CM, Van de Kar N, Vandewalle J, Zimmerhackl LB; European Paediatric Study Group for HUS. Ariceta G, et al. Pediatr Nephrol. 2009 Apr;24(4):687-96. doi: 10.1007/s00467-008-0964-1. Epub 2008 Sep 18. Pediatr Nephrol. 2009. PMID: 18800230

3

Eculizumab as rescue therapy for atypical hemolytic uremic syndrome with normal platelet count.

Dorresteijn EM, van de Kar NC, Cransberg K. Dorresteijn EM, et al. Pediatr Nephrol. 2012 Jul;27(7):1193-5. doi: 10.1007/s00467-012-2130-z. Epub 2012 Mar 8. Pediatr Nephrol. 2012. PMID: 22399074 Free PMC article.

4

Atypical hemolytic uremic syndrome in children: complement mutations and clinical characteristics.

Geerdink LM, Westra D, van Wijk JA, Dorresteijn EM, Lilien MR, Davin JC, Kömhoff M, Van Hoeck K, van der Vlugt A, van den Heuvel LP, van de Kar NC. Geerdink LM, et al. Pediatr Nephrol. 2012 Aug;27(8):1283-91. doi: 10.1007/s00467-012-2131-y. Epub 2012 Mar 13. Pediatr Nephrol. 2012. PMID: 22410797 Free PMC article.

5

Atypical hemolytic uremic syndrome and genetic aberrations in the complement factor H-related 5 gene.

Westra D, Vernon KA, Volokhina EB, Pickering MC, van de Kar NC, van den Heuvel LP. Westra D, et al. J Hum Genet. 2012 Jul;57(7):459-64. doi: 10.1038/jhg.2012.57. Epub 2012 May 24. J Hum Genet. 2012. PMID: 22622361 Free PMC article.

6

The challenge of managing hemophilia A and STEC-induced hemolytic uremic syndrome.

Westra D, Dorresteijn EM, Beishuizen A, van den Heuvel LP, Brons PP, van de Kar NC. Westra D, et al. Pediatr Nephrol. 2013 Feb;28(2):349-52. doi: 10.1007/s00467-012-2312-8. Epub 2012 Sep 23. Pediatr Nephrol. 2013. PMID: 23001024

7

An audit analysis of a guideline for the investigation and initial therapy of diarrhea negative (atypical) hemolytic uremic syndrome.

Johnson S, Stojanovic J, Ariceta G, Bitzan M, Besbas N, Frieling M, Karpman D, Landau D, Langman C, Licht C, Pecoraro C, Riedl M, Siomou E, van de Kar N, Walle JV, Loirat C, Taylor CM. Johnson S, et al. Pediatr Nephrol. 2014 Oct;29(10):1967-78. doi: 10.1007/s00467-014-2817-4. Epub 2014 May 11. Pediatr Nephrol. 2014. PMID: 24817340

8

Novel aspects of atypical haemolytic uraemic syndrome and the role of eculizumab.

Verhave JC, Wetzels JF, van de Kar NC. Verhave JC, et al. Nephrol Dial Transplant. 2014 Sep;29 Suppl 4:iv131-41. doi: 10.1093/ndt/gfu235. Nephrol Dial Transplant. 2014. PMID: 25165180 Review.

9

Discontinuation of eculizumab maintenance treatment for atypical hemolytic uremic syndrome.

Wetzels JF, van de Kar NC. Wetzels JF, et al. Am J Kidney Dis. 2015 Feb;65(2):342. doi: 10.1053/j.ajkd.2014.04.039. Am J Kidney Dis. 2015. PMID: 25616634 No abstract available.

10

An international consensus approach to the management of atypical hemolytic uremic syndrome in children.

Loirat C, Fakhouri F, Ariceta G, Besbas N, Bitzan M, Bjerre A, Coppo R, Emma F, Johnson S, Karpman D, Landau D, Langman CB, Lapeyraque AL, Licht C, Nester C, Pecoraro C, Riedl M, van de Kar NC, Van de Walle J, Vivarelli M, Frémeaux-Bacchi V; HUS International. Loirat C, et al. Pediatr Nephrol. 2016 Jan;31(1):15-39. doi: 10.1007/s00467-015-3076-8. Epub 2015 Apr 11. Pediatr Nephrol. 2016. PMID: 25859752 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

104 results

Search Page